If you build global budgets, Japan is the country that doesn’t fit the template. No grid, no line-by-line check against your FMV tool. Just a cost per patient, a few institution fees, and a note that medical expenses will be billed separately. Here’s what a Japanese budget looks like, why it’s built that way, and where the switch to FMV really stands.
A practical guide to clinical trial budgeting in Belgium, covering the regulatory timeline, site setup requirements, patient reimbursement, contracts, Power of Attorney, GDPR, withholding, and payment considerations for IGAs and budget developers.
Understanding UK clinical trial budgets starts with the time-based costing model. Unlike fixed-fee systems, each procedure is broken down by staff role and time allocation, often resulting in multiple line items for a single activity. Combined with mandatory uplifts such as indirect costs, capacity building, and Market Forces Factor (MFF), this structure can significantly increase the true cost per patient compared to initial estimates.
French budgets are compliance-driven rather than negotiation-based. Your role is to ensure strict alignment between the protocol and Appendix 2.1, as no changes can be made after approval. Appendix 4 allows some flexibility, but all requested fees should be carefully reviewed for clear justification and necessity.
